A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 42
Summary
- Conditions
- Hearing Loss, Sensorineural
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Triple (Participant, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 50 years and 75 years
- Gender
- Both males and females
Description
This study was previously posted by Pfizer, Inc. Sponsorship of the trial was transferred to Biogen.
This study was previously posted by Pfizer, Inc. Sponsorship of the trial was transferred to Biogen.
Tracking Information
- NCT #
- NCT01518920
- Collaborators
- Not Provided
- Investigators
- Study Director: Medical Director Biogen
Get Well Soon